ReviewBiosensors2026
Surface Plasmon Resonance as a Tool in Antiviral Drug Discovery Research.
Review in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Viruses are an indispensable part of the environment we live in. The occurrence of seasonal and pandemic infections underscores the urgent need to develop new antiviral drugs or repurpose existing ones. Among the methods used in research on new antiviral molecules, surface plasmon resonance (SPR) has a well-established position due to its diverse applications in interaction analysis. It can be used to investigate various molecules (proteins, nucleic acids, small-molecular drugs) in different configurations and in real time. Although it is a gold-standard method for biomolecular interaction analysis, it is not free of constraints. Here, we review research on SPR in antiviral drug discovery. We focus on experimental design and discuss the application of SPR to investigate key stages of viral infection and to characterize antiviral interactions. In addition, we address the main limitations and challenges associated with SPR measurements and consider strategies for adapting the technique to meet the specific needs of antiviral research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.